http://pharmtech.findpharma.com/pharmtech/Ingredients/Article/list/40942 Trends, market analysis, and market growth reports on pharmaceutical ingredient suppliers and manufacturers. Sourcing and supply of active pharmaceutical ingredients (APIs), intermediates, excipients. 2009-11-21T19:40:47Z http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-16-2009-GSK-and-Nabi-Form-Nicotine-Vac/ArticleStandard/Article/detail/642581?contextCategoryId=40942&ref=25 Company and People Notes: Genzyme provides updates on enzyme replacement products and FDA complete response letter; Watson appoints VP of global operations; more... 2009-11-19T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642581null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Nov-9-2009-Merck-and-Schering-Plough-Begin/ArticleStandard/Article/detail/640959?contextCategoryId=40942&ref=25 Company and People Notes: 3M forms agreement with VaxInnate; TRIN Pharma appoints CEO; More... 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640959null HTML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/AAPS-Announces-Annual-Awards-Names-2009-Fellows/ArticleStandard/Article/detail/640909?contextCategoryId=40942&ref=25 The American Association of Pharmaceutical Scientists (AAPS) recognized researchers at the organization's 2009 Annual Meeting and Exposition in Los Angeles this week. 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640909null HTML http://pharmtech.findpharma.com/pharmtech/Formulation/USP-Revises-Excipient-Standards-to-Limit-Contamina/ArticleStandard/Article/detail/639036?contextCategoryId=40942&ref=25 In response to a request from the US Food and Drug Administration, the US Pharmacopeial Convention (USP) revised its standards for propylene glycol and sorbitol solution 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639036null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?contextCategoryId=40942&ref=25 Company and People Notes: sanofi aventis forms pact with Micromet; Laureate Pharma adds members to its business team. 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639212null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/SOCMA-Hails-FDA-Action-on-Citizen-Petition-Regardi/ArticleStandard/Article/detail/639211?contextCategoryId=40942&ref=25 The Society of Chemical Manufacturers and Affiliates (SOCMA) reported last week that the US Food and Drug Administration responded to the association's citizen petition relating to the inspection process of foreign drug-manufacturing facilities. 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639211null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Lonza-Restructures-Plans-Cost-Reductions/ArticleStandard/Article/detail/639210?contextCategoryId=40942&ref=25 Lonza (Basel, Switzerland), the large contract manufacturer of small-molecule and biologic-based active pharmaceutical ingredients (APIs), announced last week a series of cost-cutting measures for the next 12 to 18 months. 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639210null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Whatever-Happened-to-Classical-Chemistry/ArticleStandard/Article/detail/639203?contextCategoryId=40942&ref=25 A recent book reminds readers that small-molecule chemistry has enabled advances in biotechnology. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639203/pt-1109-Vetterlein-book-B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639203/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639203null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Sharing-Supply-Chain-Security/ArticleStandard/Article/detail/639209?contextCategoryId=40942&ref=25 A panel of industry and regulatory experts, including FDA, discuss efforts to secure the global pharmaceutical supply chain. This article contains bonus online-exclusive material. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639209/pt1109_coverstory_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639209/Bonus_main.gif http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639209null XML http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?contextCategoryId=40942&ref=25 FDA's Edwin Rivera-Martinez on dodging supply-chain challenges. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639195null XML http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Advancing-Chiral-Chemistry-in-API-Synthesis/ArticleStandard/Article/detail/639207?contextCategoryId=40942&ref=25 Functionalized supramolecular catalysts and an enantioselective route to unnatural amino acids are some recent developments. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639207/pt-1109-p44-Ingredients_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639207null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Regulatory-Update-The-IPEC-Novel-Excipient-Safety-/ArticleStandard/Article/detail/639204?contextCategoryId=40942&ref=25 The authors, representing the International Pharmaceutical Excipients Council, propose a new evaluation procedure, including tiered toxicology testing for excipients. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639204null XML http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?contextCategoryId=40942&ref=25 While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the game too. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639194null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Targeting-Therapeutics-for-the-Middle-and-Inner-Ea/ArticleStandard/Article/detail/638761?contextCategoryId=40942&ref=25 A Conversation with Otonomy 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638761/pt1109-sup-needles-CV-B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638761null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Cargill-updates-industry-on-portfolio-innovations/ArticleStandard/Article/detail/637079?contextCategoryId=40942&ref=25 Cargill has recently announced a number of innovations connected to its range of polyol excipients. 2009-10-30T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637079null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Generic-APIs-Outstrip-Innovation/ArticleStandard/Article/detail/637179?contextCategoryId=40942&ref=25 The global API market has expanded from $69 billion in 2004 to more than $90 billion in 2008, according to a report from the Italian Chemical Pharmaceutical Association (CPA); in particular, the report noted a rapid growth rate for generic APIs. 2009-10-29T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637179null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/House-Committee-Passes-IST-Requirements-in-Chemica/ArticleStandard/Article/detail/637178?contextCategoryId=40942&ref=25 The House Energy and Commerce Committee approved H.R. 2868, the "Chemical Facility Anti-Terrorism Act of 2009," a measure to modify and codify existing requirements of the Chemical Facility Anti-Terrorism Standards (CFATS) program. 2009-10-29T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637178null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?contextCategoryId=40942&ref=25 Also, Astellas and Medivation sign development pact; WuXi PharmaTech appoints VP of business development, more... 2009-10-29T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637174null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/EFCG-Counterfeit-Medicines-More-Profitable-than-He/ArticleStandard/Article/detail/635540?contextCategoryId=40942&ref=25 The European Fine Chemicals Group (EFCG) gave an update of some of its activities at a press conference held at CPhI Worldwide (Spain) last week, and revealed some disturbing facts regarding counterfeit APIs, which the group is particularly concerned about. 2009-10-22T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635540null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Pfizer-and-Wyeth-Begin-Operations-as-a-Combined-Co/ArticleStandard/Article/detail/635536?contextCategoryId=40942&ref=25 Following the completion of its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) began joint operations of the combined company last week. 2009-10-22T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635536null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-19-2009-Lonza-Drops-Bid-for-Patheon-Pe/ArticleStandard/Article/detail/635533?contextCategoryId=40942&ref=25 Company and People Notes: SurModics forms agreement with Roche and Genentech; Hospira names Daphne Jones senior VP and chief information officer; more... 2009-10-22T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635533null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-12-2009-GSK-and-Prosensa-Form-Pact-Car/ArticleStandard/Article/detail/633981?contextCategoryId=40942&ref=25 Company and People Notes: Bayer Schering Pharma forms collaboration with Compugen; Takeda San Francisco appoints VP of process science; more... 2009-10-15T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/633981null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/USP-Issues-New-Quality-Standards-for-Heparin/ArticleStandard/Article/detail/632148?contextCategoryId=40942&ref=25 The US Food and Drug Administration issued an alert to healthcare professionals of a change in heparin manufacturing that is expected to decrease the drug's potency. 2009-10-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632148null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-5-2009-Merck-and-CSL-Sign-Flu-Vaccine-/ArticleStandard/Article/detail/632124?contextCategoryId=40942&ref=25 Company and People Notes: GSK forms joint venture with China-based Jiangsu Walvax Biotech; Sigma-Aldrich appoints VP and board member; more... 2009-10-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632124null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Companies-Update-Pandemic-H1N1-Flu-Vaccine-Project/ArticleStandard/Article/detail/632147?contextCategoryId=40942&ref=25 GlaxoSmithKline (London), Novartis (Basel, Switzerland), sanofi Aventis (Paris), and Baxter International (Deerfield, IL) recently provided updates as to the development, manufacture, or shipment of pandemic (H1NI) vaccines. 2009-10-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632147null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Nobel-Prize-Awarded-for-Research-in-the-Role-of-a-/ArticleStandard/Article/detail/632128?contextCategoryId=40942&ref=25 The 2009 Nobel Prize in Physiology or Medicine was awarded to three US researchers for the discovery of how chromosomes are protected from degradation by telomeres and the enzyme telomerase during cell division. 2009-10-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632128null HTML http://pharmtech.findpharma.com/pharmtech/IT/Looking-Ahead-The-Pharmaceutical-Science-Industry/ArticleStandard/Article/detail/631750?contextCategoryId=40942&ref=25 AAPS President offers hope and solutions for the industry's challenging future. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631750null XML http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Delivering-the-Results-in-Drug-Based-Nanotechnolog/ArticleStandard/Article/detail/631719?contextCategoryId=40942&ref=25 New nanotechnology-based delivery systems offer promise in drug delivery, particularly for anticancer therapeutics. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631719/ingred_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631719null XML http://pharmtech.findpharma.com/pharmtech/IT/PhRMAs-Stake-in-Reform/ArticleStandard/Article/detail/631752?contextCategoryId=40942&ref=25 The nation's healtcare system needs an overhaul, but it has to be done right. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631752null XML http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Defining-the-ideal-properties-of-a-moisture-protec/ArticleStandard/Article/detail/629823?contextCategoryId=40942&ref=25 Applying a moisture protective barrier to tablet cores can help prevent degradation caused by ambient moisture. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629823/Cech_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629823null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Abbott-to-Acquire-Solvay-Pharmaceuticals-for-66-Bi/ArticleStandard/Article/detail/630294?contextCategoryId=40942&ref=25 Abbott Laboratories (Abbott Park, IL) agreed to acquire the pharmaceutical business of the Solvay Group (Brussels, Belgium) for EUR 4.5 billion ($6.6 billion) in cash, according to an Abbott press release. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630294null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-28-2009-JampJ-and-Crucell-Enter-Colla/ArticleStandard/Article/detail/630279?contextCategoryId=40942&ref=25 Company and People Notes: Boehringer Ingelheim will acquire Wyeth's animal health business; Amsterdam Molecular Therapeutics appoints CEO; more... 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630279null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Seattle-Genetics-Introduces-Sugar-Engineered-Antib/ArticleStandard/Article/detail/630293?contextCategoryId=40942&ref=25 The biopharmaceutical company Seattle Genetics (Bothell, WA) introduced a sugar-engineered antibody (SEA) technology that is designed to increase the potency of monoclonal antibodies through enhanced effector function. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630293null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-21-2009-AstraZeneca-and-Nektar-Sign-L/ArticleStandard/Article/detail/628576?contextCategoryId=40942&ref=25 Company and People Notes: Wyeth and Ambrx form development pact; Elite Pharma appoints CEO and CSO; more... 2009-09-24T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628576null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Bayer-Receives-Warning-Letter-for-Alleged-Deviatio/ArticleStandard/Article/detail/628581?contextCategoryId=40942&ref=25 The US Food and Drug Administration sent Bayer Schering Pharma (Berlin) a Warning Letter on Aug. 5, 2009, citing deviations from current good manufacturing practice in the manufacture of nonsterile active pharmaceutical ingredients (APIs). 2009-09-24T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628581null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-14-2009-Evotec-and-Biogen-Idec-Form-P/ArticleStandard/Article/detail/626906?contextCategoryId=40942&ref=25 Company and People Notes: Sanofi Pasteur signs H1N1 vaccine deal with Brazilian government; Helsinn Group appoints CEO of US business; more... 2009-09-17T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626906null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-7-2009-Facet-Rejects-Biogen-Idecs-Pro/ArticleStandard/Article/detail/624922?contextCategoryId=40942&ref=25 Company and People Notes: Neoprobe and Laureate Pharma form manufacturing agreement; Akela Pharma appoints CEO and chairman; more... 2009-09-10T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624922null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Aug-31-2009-Roche-Purchases-Lonza-Facility/ArticleStandard/Article/detail/623587?contextCategoryId=40942&ref=25 Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more... 2009-09-03T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623587null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/USP-to-Develop-Standards-with-Mexican-Commission/ArticleStandard/Article/detail/623593?contextCategoryId=40942&ref=25 The US Pharmacopeial Convention (USP) and the Permanent Commission of the Pharmacopeia of the United Mexican States (FEUM) signed a memorandum of understanding (MOU) last week. 2009-09-03T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623593null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Its-Easy-Being-Green/ArticleStandard/Article/detail/624194?contextCategoryId=40942&ref=25 An outstanding new book reviews alternative solvents with an eye to sustainable pharmaceutical processes. 2009-09-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624194/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624194null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Pharma-Capsules/ArticleStandard/Article/detail/625569?contextCategoryId=40942&ref=25 Brief pharmaceutical news items for September 2009. 2009-09-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/625569null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Green-API-Manufacturing/ArticleStandard/Article/detail/624201?contextCategoryId=40942&ref=25 Pfizer uses green-chemistry in a second-generation manufacturing route for gabapentin. 2009-09-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624201/GREEN_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624201null XML http://pharmtech.findpharma.com/pharmtech/IT/Quality-by-Enforcement/ArticleStandard/Article/detail/624202?contextCategoryId=40942&ref=25 After years of promomting QbD concepts, FDA's ready to take action on nonconformers. 2009-09-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624202null XML http://pharmtech.findpharma.com/pharmtech/IT/The-GoNo-Go-Mindset/ArticleStandard/Article/detail/624651?contextCategoryId=40942&ref=25 As new process validation guidelines emerge, industry needs to reinvent how it releases product. 2009-09-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624651null XML http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Tracking-CMO-Activity/ArticleStandard/Article/detail/624204?contextCategoryId=40942&ref=25 Select contract manufacturing organizations roll out expansions for production of active pharmaceutical ingredients and intermediates. 2009-09-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624204null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Inside-IPECndashAmericas-Evaluating-Excipient-Stab/ArticleStandard/Article/detail/624205?contextCategoryId=40942&ref=25 IPEC's new stability testing guide takes into account the full supply chain's storage conditions. 2009-09-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624205null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/A-Green-Manufacturing-Route-to-Testosterone/ArticleStandard/Article/detail/624208?contextCategoryId=40942&ref=25 A second-generation and green manufacturing process for testosterone provided economic and ecological benefits. 2009-09-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624208/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624208null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Applying-Biocatalysis-A-Technical-Forum/ArticleStandard/Article/detail/623098?contextCategoryId=40942&ref=25 Scientists from DSM and Kaneka discuss various techniques in this roundtable moderated by Patricia Van Arnum. 2009-09-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623098null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Orally-Disintegrating-Tablets-The-Effect-of-Recent/ArticleStandard/Article/detail/623097?contextCategoryId=40942&ref=25 The authors describe the various available technologies used in orally disintegrating tablets. 2009-09-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623097/Supp_18_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623097null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Using-Microreactors-in-Chemical-Synthesis-Batch-Pr/ArticleStandard/Article/detail/623095?contextCategoryId=40942&ref=25 The authors discuss the advantages of microreactors and flow chemistry for various reaction types in achieving improved process economics and reaction efficiency. 2009-09-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623095/Supp_6_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623095null XML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Aug-24-2009-Warner-Chilcott-Buys-PampG-Pha/ArticleStandard/Article/detail/621551?contextCategoryId=40942&ref=25 Company and People Notes: UCB and Novartis form agreement; AAIPharma appoints VP of regulatory affairs; more... 2009-08-27T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621551null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Extending-Calibrations-for-Near-Infrared-Assay-of-/ArticleStandard/Article/detail/621672?contextCategoryId=40942&ref=25 The range of a Near-Infrared (NIR) calibration model for tablet assay was extended using production "seed" spectra and synthetic spectra generated from placebos and "pure" API spectra. This method resolves the problem of not being able to obtain a range of production samples with +/- 15% of the label claim of API concentration online. 2009-08-26T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621672null REMOTE http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Forest-Labs-and-AstraZene/ArticleStandard/Article/detail/620144?contextCategoryId=40942&ref=25 Also, XCELERON and GSK form agreement; Millipore appoints VP of life sciences; more... 2009-08-20T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620144null HTML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-Roundup-FDA-Reorganizes-the-Office-of-t/ArticleStandard/Article/detail/620139?contextCategoryId=40942&ref=25 Also, FDA publishes draft guidances of two ICH Annexes; EMEA sets format for compliance advice; more... 2009-08-20T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620139null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/UK-Researchers-Target-Marine-Microbes-for-Green-Ma/ArticleStandard/Article/detail/618414?contextCategoryId=40942&ref=25 Manufacturing methods for new drugs could be made greener and more efficient with the help of marine microbes. 2009-08-20T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/618414null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Industry-Considers-Green-Chemistry-Standards/ArticleStandard/Article/detail/620134?contextCategoryId=40942&ref=25 An initiative to develop consensus-based industry standards to identify and define green chemicals and process technologies is underway. 2009-08-20T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620134null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Companies-Update-Activities-for-Pandemic-and-Seaso/ArticleStandard/Article/detail/618411?contextCategoryId=40942&ref=25 Baxter International (Deerfield, IL), sanofi aventis (Paris), and Novartis (Basel, Switzerland) provided updates last week of their production and regulatory activities relating to preparedness in supplying the A(H1N1) pandemic influenza vaccine. Novartis also outlined its activities for providing seasonal flu vaccines. 2009-08-13T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/618411null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Nabi-and-GSK-Form-Pact-Ca/ArticleStandard/Article/detail/618405?contextCategoryId=40942&ref=25 Also: DSM's North Carolina facility receives SafeBridge certification; Dynavax CFO to retire; more... 2009-08-13T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/618405null HTML http://pharmtech.findpharma.com/pharmtech/Whitepapers/Near-Infrared-Assay-and-Content-Uniformity-of-Tabl/ArticleStandard/Article/detail/523511?contextCategoryId=40942&ref=25 Near-Infrared (NIR) technique for the determination of content uniformity of tablets provides a fast and accurate means of monitoring tablet production that is in step with the FDA Process Analytical Technology (PAT) initiatives. The FOSS XDS MasterLab™ was used to determine the content uniformity of tablets, instrument precision and accuracy. The data showed promising results that could relieve laboratory workload from HPLC analysis and bring analysis closer to "real-time" for process monitoring. 2009-08-07T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523511null REMOTE http://pharmtech.findpharma.com/pharmtech/Whitepapers/In-Situ-Monitoring-of-CHO-Cell-Culture-Medium-Usin/ArticleStandard/Article/detail/523510?contextCategoryId=40942&ref=25 NIR spectroscopy using specialized transmission probes and fiber optics allows real-time in situ analysis of bioreactor feed stocks and product. With continuous NIR analysis, metabolic parameters and culture media constituents can be better monitored and controlled, which increases CHO cell life and lengthens the production phase. 2009-08-07T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523510null REMOTE http://pharmtech.findpharma.com/pharmtech/Ingredients/EU-Issues-Study-on-REACH-Implementation/ArticleStandard/Article/detail/616591?contextCategoryId=40942&ref=25 The Society of Chemical Manufacturers and Affiliates (SOCMA) reported in late July that Eurostat, the Statistical Office of the European Communities, recently published a baseline study or the first snapshot of REACH policy in the preregistration phase. 2009-08-06T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322009/616591null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Cherokee-and-DuPont-Form-/ArticleStandard/Article/detail/616603?contextCategoryId=40942&ref=25 Also, Pfizer forms two research agreements in China; NanoInk appoints John Kubricky to its scientific advisory board; more... 2009-08-06T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322009/616603null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Pharma-Capsules/ArticleStandard/Article/detail/615826?contextCategoryId=40942&ref=25 Brief pharmaceutical news items for August 2009. 2009-08-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615826null XML http://pharmtech.findpharma.com/pharmtech/IT/Of-Hubris-and-Happy-Endings/ArticleStandard/Article/detail/615813?contextCategoryId=40942&ref=25 Individuals and companies at the top seem to have no problem short-circuiting their success. 2009-08-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615813null XML http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Shifting-Fortunes-in-API-Market-Growth/ArticleStandard/Article/detail/615825?contextCategoryId=40942&ref=25 Biologics enhance their positions amidst slowing growth in the global and US markets. 2009-08-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615825null XML http://pharmtech.findpharma.com/pharmtech/IT/For-Biotherapeutics-Innovation-is-Not-Enough/ArticleStandard/Article/detail/615816?contextCategoryId=40942&ref=25 Biotech firms must first close the gaps between science and biology on the path toward QbD. 2009-08-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615816null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Global-Outsourcing-A-Roundtable-of-Contract-Manufa/ArticleStandard/Article/detail/615507?contextCategoryId=40942&ref=25 Leading contract manufacturing organizations share their views on the current and future market dynamics shaping pharmaceutical outsourcing. 2009-08-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615507null XML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Notes-Amgen-and-GSK-/ArticleStandard/Article/detail/614815?contextCategoryId=40942&ref=25 Also, Isogen completes sterile facility; Dishman appoints head of generic API business; FDA releases final rule on authorized generic drugs and NDA submissions; more... 2009-07-30T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/614815null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Briefs-Teva-and-Orth/ArticleStandard/Article/detail/612961?contextCategoryId=40942&ref=25 Also, Gilead and Tibotec form agreement; FDA approves 2009-2010 flu vaccine; Catalent appoints VP in packaging unit; more... 2009-07-23T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302009/612961null HTML http://pharmtech.findpharma.com/pharmtech/News/SOCMA-Supports-Extension-of-CFATS/ArticleStandard/Article/detail/611028?contextCategoryId=40942&ref=25 The Society of Chemical Manufacturers and Affiliates (SOCMA) this week stated its support to the US Senate for approving legislation that would extend existing chemical security standards for one more year. 2009-07-16T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292009/611028null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Merck-and-Portola-Sign-Ag/ArticleStandard/Article/detail/611109?contextCategoryId=40942&ref=25 Also, Lonza and Medarex sign agreement; Covance appoints VP and chief scientific officer of global analytical services; more... 2009-07-16T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292009/611109null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/JampJ-Invests-15-Billion-in-Deal-with-Elan/ArticleStandard/Article/detail/609489?contextCategoryId=40942&ref=25 Johnson & Johnson has agreed to pay $1.0 billion to acquire the assets and rights of the Alzheimer's immunotherapy program of the biopharmaceutical company Elan, form a new company with Elan based on the AIP program, and gain an 18.4% stake in Elan. 2009-07-09T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282009/609489null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-and-Graceway-Form-/ArticleStandard/Article/detail/609491?contextCategoryId=40942&ref=25 Also, Lundbeck acquired LifeHealth; FDA is seeking a director of its new tobacco regulation branch; Charles River Labs announces personnel changes; more... 2009-07-09T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282009/609491null HTML http://pharmtech.findpharma.com/pharmtech/Article/Deploying-Green-Chemistry-in-API-Synthesis/ArticleStandard/Article/detail/608517?contextCategoryId=40942&ref=25 Advances in micellar catalysis, solid-state chemistry, catalytic asymmetric synthesis, and function-oriented synthesis for natural products represent noteworthy developments in green chemistry that can be applied to the synthesis of active pharmaceutical ingredients. 2009-07-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/608517null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Manufacturers-Face-New-Risk-Management-Requirement/ArticleStandard/Article/detail/607455?contextCategoryId=40942&ref=25 REMS to improve the safe use of opioids may lead to controls on other high-risk medicines. 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607455null XML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?contextCategoryId=40942&ref=25 Also, Wyeth and Catalyst sign agreement; FDA seeks public opinion about tobacco regulation; Catalent appoints VP of quality and regulatory affairs; more... 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607999null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/USP-Collaborates-with-Asian-Authorities/ArticleStandard/Article/detail/608009?contextCategoryId=40942&ref=25 This week, the US Pharmacopeial Convention and the Vietnamese Pharmacopoeia Commission signed a memorandum of understanding that will help ensure the safety of Vietnamese medicines. 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/608009null HTML http://pharmtech.findpharma.com/pharmtech/IT/The-Good-Society/ArticleStandard/Article/detail/607467?contextCategoryId=40942&ref=25 Is it good policy to pay for bad behavior? 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607467null XML http://pharmtech.findpharma.com/pharmtech/IT/Can-Industry-Learn-to-Share/ArticleStandard/Article/detail/607463?contextCategoryId=40942&ref=25 The regulators are doing it. But industry's fear of sharing information may leave them behind. 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607463null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Traditional-Chinese-Medicines-and-Western-Regulato/ArticleStandard/Article/detail/607454?contextCategoryId=40942&ref=25 Traditional Chinese Medicine is widely used, but questions persist regarding its regulatory status. 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607454null XML http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Examining-High-Potency-API-Manufacturing/ArticleStandard/Article/detail/607456?contextCategoryId=40942&ref=25 High-potency manufacturing of active pharmaceutical ingredients is a growing and specialized capability. 2009-07-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607456null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Watson-to-Acquire-Arrow-for-175-Billion/ArticleStandard/Article/detail/606176?contextCategoryId=40942&ref=25 Generic-drug and specialty pharmaceutical manufacturer Watson Pharmaceuticals (Corona, CA) agreed to acquire the generic-drug company Arrow Group for $1.75 billion in cash and stock. 2009-06-25T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/606176null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?contextCategoryId=40942&ref=25 Also, Adimab forms deals with Merck and Roche; Manhattan Pharmaceuticals' CEO and president steps down; more... 2009-06-25T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/606500null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/European-Fine-Chemicals-Group-Issues-Assessment-To/ArticleStandard/Article/detail/606178?contextCategoryId=40942&ref=25 Following the 2008 launch of the European Fine Chemicals Group (EFCG) Voluntary Guidelines (VGs) to promote supply-chain security, the group has now announced the official launch of an assessment template that will allow fine chemicals customers and suppliers to assess and implement this new set of recommendations. 2009-06-25T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/606178null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?contextCategoryId=40942&ref=25 Also, FDA debars clinical investigators; Jubilant Organosys forms deal with Endo Pharmaceuticals; AMRI makes changes to its India management team; more... 2009-06-18T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/604472null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/FTC-Report-on-Follow-on-Biologics-Sparks-Congressi/ArticleStandard/Article/detail/604402?contextCategoryId=40942&ref=25 The Subcommittee on Health of the US House of Representatives Energy and Commerce Committee held hearings last week to discuss the findings of a report by the Federal Trade Commission (FTC) that examined the competitive effects for follow-on-biologics (FOBs). 2009-06-18T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/604402null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?contextCategoryId=40942&ref=25 Also, TorreyPines Therapeutics to liquidate assets and dissolve company; EU's competition services to examine Pfizer/Wyeth merger; Akorn appoints Raj Rai interim CEO; more... 2009-06-11T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602720null HTML http://pharmtech.findpharma.com/pharmtech/News/European-Commission-Wont-Pursue-Directive-for-Exci/ArticleStandard/Article/detail/602697?contextCategoryId=40942&ref=25 The European Commission's (EC) Directorate-General for Enterprise and Industry (EC-DG Enterprise) announced last week that it will not continue preparing a commission directive on good manufacturing practices (GMPs) for certain excipients. 2009-06-11T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602697null HTML http://pharmtech.findpharma.com/pharmtech/Article/Bleak-Times-for-the-Global-Biotech-Industry/ArticleStandard/Article/detail/601471?contextCategoryId=40942&ref=25 The US biotechnology industry reached aggregate profitability for the first time ever in 2008, representing the only bright spot in an otherwise dismal year for biotechnology financing and performance. 2009-06-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601471null HTML http://pharmtech.findpharma.com/pharmtech/Article/Best-Practices-in-the-Supply-Chain/ArticleStandard/Article/detail/601481?contextCategoryId=40942&ref=25 Consumer-care products, electronics, and select industrial firms comprise AMR Research's Supply Chain Top 25 for 2009, offering an opportunity for the pharmaceutical industry to examine best practices in supply-chain management. 2009-06-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601481null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?contextCategoryId=40942&ref=25 Also, WACKER expands Iowa facility; EMEA releases a Q&A document for PIPs; Metrics consolidates quality operations; more... 2009-06-04T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601645null HTML http://pharmtech.findpharma.com/pharmtech/News/House-Introduces-Discussion-Draft-for-Drug-and-Foo/ArticleStandard/Article/detail/601252?contextCategoryId=40942&ref=25 Members of the House Committee on Energy and Commerce, Chair Emeritus John D. Dingell (D-MI), Chair Henry A. Waxman (D-CA), and Reps. Frank Pallone (D-NJ), Bart Stupak (D-MI), Diana DeGette (D-CO) and Betty Sutton (D-OH) released last week a discussion draft of the Food Safety Enhancement Act of 2009. 2009-06-04T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601252null HTML http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?contextCategoryId=40942&ref=25 Misleading the public about their investments—be it money or medicine—is unacceptable. 2009-06-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600808null XML http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?contextCategoryId=40942&ref=25 It can take a lot of work to make sure nothing happens. 2009-06-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600812null XML http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Outsourcing-Clinical-Trial-Materials/ArticleStandard/Article/detail/600809?contextCategoryId=40942&ref=25 CROs and CMOs expand to gain a piece of the market for clinical trial materials. 2009-06-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600809/rotate_ingredients_flash.jpg XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Initial-Solvent-Screening-of-Carbamazepine-Cimetid/ArticleStandard/Article/detail/601168?contextCategoryId=40942&ref=25 The authors describe the importance of a rapid and an abbreviated screening strategy in initial solvent screening. This article contains bonus online-exclusive material. 2009-06-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601168/Bonus_main.gif http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601168null XML http://pharmtech.findpharma.com/pharmtech/Latest+News/Twice-as-many-therapeutic-peptides-in-the-clinic/ArticleStandard/Article/detail/599867?contextCategoryId=40942&ref=25 Thanks to advances in synthesis, delivery and formulation, the number of therapeutic peptides entering clinical trials this decade is almost double the rate of the 1990s, and investment in new therapeutic peptide product development is expected to continue at a strong pace for the foreseeable future. 2009-05-29T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/222009/599867null HTML http://pharmtech.findpharma.com/pharmtech/APIs/Next-generation-of-API-purification-technologies/ArticleStandard/Article/detail/599864?contextCategoryId=40942&ref=25 A consortium with a specific focus on removing organic impurities from API production has been selected by the European Commission (EC) to receive funding of approximately 3 million euro. 2009-05-29T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/222009/599864null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?contextCategoryId=40942&ref=25 Also, Johnson & Johnson acquires Cougar Biotechnology; NIH launches program for rare and neglected diseases; PPD restructures leadership positions; more... 2009-05-28T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600299null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/ADM-Plans-Green-Production-for-USP-Grade-Propylene/ArticleStandard/Article/detail/600065?contextCategoryId=40942&ref=25 Archers Daniel Midland Company (Decatur, IL) is bringing on line a new propylene glycol plant in Decatur, Illinois, in the fourth quarter of 2009. 2009-05-28T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600065null HTML